Concepedia

M.D. Galsky

MG

Statistics

Publications

1

Citations

25

H-Index

1

Active since

2024

Affiliations

Jewish General Hospital(Current)

M.D. Galsky is an author at Jewish General Hospital specializing in pharmacology, metastatic urothelial carcinoma immunotherapy, and human epidermal growth factor receptor 2-targeted therapy.

Publications per year

2024–2024

1

Publications

1

1967MO Preliminary efficacy and safety of disitamab vedotin (DV) with pembrolizumab (P) in treatment (Tx)-naive HER2-expressing, locally advanced or metastatic urothelial carcinoma (la/mUC): RC48G001 cohort C

M.D. Galsky, Vadim S. Koshkin, Matthew T. Campbell et al. · Annals of Oncology · 2024 · 25 citations

, , +16

1–1 of 1